These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 27898267)

  • 1. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
    Monastra G; Unfer V; Harrath AH; Bizzarri M
    Gynecol Endocrinol; 2017 Jan; 33(1):1-9. PubMed ID: 27898267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositols in Polycystic Ovary Syndrome: An Overview on the Advances.
    Facchinetti F; Unfer V; Dewailly D; Kamenov ZA; Diamanti-Kandarakis E; Laganà AS; Nestler JE; Soulage CO;
    Trends Endocrinol Metab; 2020 Jun; 31(6):435-447. PubMed ID: 32396844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.
    Nordio M; Proietti E
    Eur Rev Med Pharmacol Sci; 2012 May; 16(5):575-81. PubMed ID: 22774396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on inositol(s) for PCOS therapy: steps toward success.
    Nestler JE; Unfer V
    Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome.
    Dinicola S; Chiu TT; Unfer V; Carlomagno G; Bizzarri M
    J Clin Pharmacol; 2014 Oct; 54(10):1079-92. PubMed ID: 25042908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives.
    Paul C; Laganà AS; Maniglio P; Triolo O; Brady DM
    Gynecol Endocrinol; 2016 Jun; 32(6):431-8. PubMed ID: 26927948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.
    Unfer V; Porcaro G
    Expert Rev Clin Pharmacol; 2014 Sep; 7(5):623-31. PubMed ID: 24898153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experts' opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond.
    Facchinetti F; Appetecchia M; Aragona C; Bevilacqua A; Bezerra Espinola MS; Bizzarri M; D'Anna R; Dewailly D; Diamanti-Kandarakis E; Hernández Marín I; Kamenov ZA; Kandaraki E; Laganà AS; Monastra G; Montanino Oliva M; Nestler JE; Orio F; Ozay AC; Papalou O; Pkhaladze L; Porcaro G; Prapas N; Soulage CO; Stringaro A; Wdowiak A; Unfer V
    Expert Opin Drug Metab Toxicol; 2020 Mar; 16(3):255-274. PubMed ID: 32129111
    [No Abstract]   [Full Text] [Related]  

  • 11. Inositols' Importance in the Improvement of the Endocrine-Metabolic Profile in PCOS.
    Wojciechowska A; Osowski A; Jóźwik M; Górecki R; Rynkiewicz A; Wojtkiewicz J
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inositol: history of an effective therapy for Polycystic Ovary Syndrome.
    Bizzarri M; Carlomagno G
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1896-903. PubMed ID: 25010620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.
    Fedeli V; Catizone A; Querqui A; Unfer V; Bizzarri M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Myo-Inositol and D-Chiro-Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome Classified as Phenotype A by the Rotterdam Criteria and EMS-Type 1 by the EGOI Criteria.
    Pustotina O; Myers SH; Unfer V; Rasulova I
    Gynecol Obstet Invest; 2024; 89(2):131-139. PubMed ID: 38295772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositol as putative integrative treatment for PCOS.
    Genazzani AD
    Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inositols: From Established Knowledge to Novel Approaches.
    Dinicola S; Unfer V; Facchinetti F; Soulage CO; Greene ND; Bizzarri M; Laganà AS; Chan SY; Bevilacqua A; Pkhaladze L; Benvenga S; Stringaro A; Barbaro D; Appetecchia M; Aragona C; Bezerra Espinola MS; Cantelmi T; Cavalli P; Chiu TT; Copp AJ; D'Anna R; Dewailly D; Di Lorenzo C; Diamanti-Kandarakis E; Hernández Marín I; Hod M; Kamenov Z; Kandaraki E; Monastra G; Montanino Oliva M; Nestler JE; Nordio M; Ozay AC; Papalou O; Porcaro G; Prapas N; Roseff S; Vazquez-Levin M; Vucenik I; Wdowiak A
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.
    Kachhawa G; Senthil Kumar KV; Kulshrestha V; Khadgawat R; Mahey R; Bhatla N
    Int J Gynaecol Obstet; 2022 Aug; 158(2):278-284. PubMed ID: 34624138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients: comparison with other ratios.
    Nordio M; Basciani S; Camajani E
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5512-5521. PubMed ID: 31298405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bye-bye chiro-inositol - myo-inositol: true progress in the treatment of polycystic ovary syndrome and ovulation induction.
    Galletta M; Grasso S; Vaiarelli A; Roseff SJ
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1212-4. PubMed ID: 22165685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS).
    Fruzzetti F; Perini D; Russo M; Bucci F; Gadducci A
    Gynecol Endocrinol; 2017 Jan; 33(1):39-42. PubMed ID: 27808588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.